Exposing Congressional Drug Abuse Act
HCONRES 35, the Exposing Congressional Drug Abuse Act, would require all members of the U.S. House of Representatives and Senate - including delegates and resident commissioners - to undergo random, unannounced drug tests once per legislative term. Confirmed positive results for illegal drugs (verified by a second test and medical review) would be shared with the member and their chamber's ethics committee, which must publicly disclose any refusal to test. Members would cover the cost of their own tests, and ethics committees would take appropriate action against those who decline participation. This procedural resolution aims to establish internal drug testing standards for congressional members.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jun 2025
Committee Review
Floor Vote
President
Introduced Jun 5, 2025
Last action Jun 5, 2025
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Jun 5, 2025
Committee
Referred to the House Committee on House Administration.
lower
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Clay Higgins
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about HCONRES 35
Scope: US
Hi! I can help you understand HCONRES 35. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline